Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-03-30

FDA Approved: MOEXIPRIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's moexipril hydrochloride as an Original Application (ANDA) for a generic version of an ACE inhibitor used to treat hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moexipril hydrochloride (Moexipril hydrochloride)

Snippet

ORIG AP for MOEXIPRIL HYDROCHLORIDE (MOEXIPRIL HYDROCHLORIDE)